629 related articles for article (PubMed ID: 2105643)
1. Correlation between lupus anticoagulants and anticardiolipin antibodies in patients with prolonged activated partial thromboplastin times.
Alving BM; Barr CF; Tang DB
Am J Med; 1990 Feb; 88(2):112-6. PubMed ID: 2105643
[TBL] [Abstract][Full Text] [Related]
2. Binding specificity of lupus anticoagulants and anticardiolipin antibodies.
McNeil HP; Chesterman CN; Krilis SA
Thromb Res; 1988 Dec; 52(6):609-19. PubMed ID: 3148207
[TBL] [Abstract][Full Text] [Related]
3. Lupus anticoagulant: clinical significance in anticardiolipin positive patients with systemic lupus erythematosus.
McHugh NJ; Moye DA; James IE; Sampson M; Maddison PJ
Ann Rheum Dis; 1991 Aug; 50(8):548-52. PubMed ID: 1909518
[TBL] [Abstract][Full Text] [Related]
4. Antiphospholipid antibodies and recurrent pregnancy loss: correlation between the activated partial thromboplastin time and antibodies against phosphatidylserine and cardiolipin.
Rote NS; Dostal-Johnson D; Branch DW
Am J Obstet Gynecol; 1990 Aug; 163(2):575-84. PubMed ID: 2117391
[TBL] [Abstract][Full Text] [Related]
5. Coagulation screen is more specific than the anticardiolipin antibody ELISA in defining a thrombotic subset of lupus patients.
Derksen RH; Hasselaar P; Blokzijl L; Gmelig Meyling FH; De Groot PG
Ann Rheum Dis; 1988 May; 47(5):364-71. PubMed ID: 3133992
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of lupus anticoagulant and anticardiolipin antibodies in a healthy population.
Shi W; Krilis SA; Chong BH; Gordon S; Chesterman CN
Aust N Z J Med; 1990 Jun; 20(3):231-6. PubMed ID: 2115326
[TBL] [Abstract][Full Text] [Related]
7. The prevalence and biologic significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population.
Lockwood CJ; Romero R; Feinberg RF; Clyne LP; Coster B; Hobbins JC
Am J Obstet Gynecol; 1989 Aug; 161(2):369-73. PubMed ID: 2504043
[TBL] [Abstract][Full Text] [Related]
8. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies.
Viveros ME; Cabiedes J; Reyes E; Cabral AR
Rev Invest Clin; 2005; 57(4):563-71. PubMed ID: 16315641
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of various ELISA assays for detecting antiphospholipid antibodies.
Falcón CR; Hoffer AM; Forastiero RR; Carreras LO
Thromb Haemost; 1990 Aug; 64(1):21-5. PubMed ID: 2125755
[TBL] [Abstract][Full Text] [Related]
10. Studies on the relationship between 'antiphospholipid' antibodies and the lupus anticoagulant.
Exner T; McRea J
Blood Coagul Fibrinolysis; 1990; 1(1):17-21. PubMed ID: 2129389
[TBL] [Abstract][Full Text] [Related]
11. Detection of antiphospholipid antibodies by ELISA-method with bovine thromboplastin as antigen.
López-Soto A; Casals FJ; Font J; Cervera R; Ingelmo M
Thromb Res; 1989 Mar; 53(6):623-8. PubMed ID: 2499948
[No Abstract] [Full Text] [Related]
12. Anticardiolipin antibodies and lupus anticoagulants comprise separate antibody subgroups with different phospholipid binding characteristics.
McNeil HP; Chesterman CN; Krilis SA
Br J Haematol; 1989 Dec; 73(4):506-13. PubMed ID: 2514785
[TBL] [Abstract][Full Text] [Related]
13. Methods for detecting lupus anticoagulants and their relation to thrombosis and miscarriage in patients with systemic lupus erythematosus.
Ferro D; Saliola M; Quintarelli C; Valesini G; Basili S; Grandilli AM; Bonavita MS; Violi F
J Clin Pathol; 1992 Apr; 45(4):332-8. PubMed ID: 1577971
[TBL] [Abstract][Full Text] [Related]
14. Association of lupus anticoagulant and anticardiolipin antibodies with thrombosis in patients with systemic lupus erythematosus, primary antiphospholipid syndrome and other disorders.
Brenner B; Tavori S; Lerner M; Tatarsky I; Lorber M
Isr J Med Sci; 1992 Jan; 28(1):9-15. PubMed ID: 1733904
[TBL] [Abstract][Full Text] [Related]
15. Specificity and sensitivity of diluted aPTT and anticardiolipin antibodies towards thrombosis and miscarriages in patients with systemic lupus erythematosus.
Ferro D; Saliola M; Quintarelli C; Carlucci M; Valesini G; Violi F
Thromb Res; 1990 Aug; 59(3):609-17. PubMed ID: 2122546
[TBL] [Abstract][Full Text] [Related]
16. Anticardiolipin antibodies in patients with venous thrombosis.
Kapiotis S; Speiser W; Pabinger-Fasching I; Kyrle PA; Lechner K
Haemostasis; 1991; 21(1):19-24. PubMed ID: 1907589
[TBL] [Abstract][Full Text] [Related]
17. The relationship between lupus anticoagulants and antibodies to phospholipid.
Triplett DA; Brandt JT; Musgrave KA; Orr CA
JAMA; 1988 Jan 22-29; 259(4):550-4. PubMed ID: 3121871
[TBL] [Abstract][Full Text] [Related]
18. Anticardiolipin antibodies in acquired immunodeficiency syndrome.
Stimmler MM; Quismorio FP; McGehee WG; Boylen T; Sharma OP
Arch Intern Med; 1989 Aug; 149(8):1833-5. PubMed ID: 2504122
[TBL] [Abstract][Full Text] [Related]
19. Anticardiolipin antibodies and lupus anticoagulant in patients treated with different methods of renal replacement therapy in comparison to patients with systemic lupus erythematosus.
Sitter T; Spannagl M; Schiffl H
Ann Hematol; 1992 Aug; 65(2):79-82. PubMed ID: 1511061
[TBL] [Abstract][Full Text] [Related]
20. Chlorpromazine-induced anticardiolipin antibodies and lupus anticoagulant: absence of thrombosis.
Canoso RT; de Oliveira RM
Am J Hematol; 1988 Apr; 27(4):272-5. PubMed ID: 3128108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
